Study ID: C38072-AS-30066 | 2016-004661-23

Study Title

A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Teva Identifier

C38072-AS-30066 | 2016-004661-23

ClinicalTrials.gov Identifier

NCT03052725

Study Status

Terminated

Trial Condition(s)

Eosinophils, Asthma

Interventions

Drug: reslizumab

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

March 10, 2017 - February 22, 2018

Phase

Phase 3

Study Type

Interventional